2022
DOI: 10.1007/s10792-022-02601-1
|View full text |Cite
|
Sign up to set email alerts
|

Clinical outcomes of canaloplasty via an ab-interno surgical technique using the iTrack device: a narrative review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 35 publications
0
2
0
Order By: Relevance
“…In our study, we have performed ab-interno canaloplasty, which is a nonimplant MIGS that targets all resistance sites of the conventional outflow pathway, offering a comprehensive approach to IOP reduction, with no disruption to the trabecular meshwork 15,16 . Its effectiveness in reducing IOP and medication burden is proven in the literature 17 as well as in our previous study that presented the 4-year outcomes, highlighting that IOP and medication reduction were sustained up to 48 months postoperatively 7 . In this study, the same cohort confirms that these benefits provided by canaloplasty are still sustained 6 years after the procedure, with a mean reduction in IOP and number of medications of 27% and 52%, respectively, at the last follow-up.…”
Section: Discussionmentioning
confidence: 99%
“…In our study, we have performed ab-interno canaloplasty, which is a nonimplant MIGS that targets all resistance sites of the conventional outflow pathway, offering a comprehensive approach to IOP reduction, with no disruption to the trabecular meshwork 15,16 . Its effectiveness in reducing IOP and medication burden is proven in the literature 17 as well as in our previous study that presented the 4-year outcomes, highlighting that IOP and medication reduction were sustained up to 48 months postoperatively 7 . In this study, the same cohort confirms that these benefits provided by canaloplasty are still sustained 6 years after the procedure, with a mean reduction in IOP and number of medications of 27% and 52%, respectively, at the last follow-up.…”
Section: Discussionmentioning
confidence: 99%
“…Pressure parameters provide an important basis for understanding the changes in the internal environment and the damage to surrounding tissues. Pressure microcatheters can also be used for pressure testing of intracardiac pressure, pulmonary artery pressure, intrarenal pressure, and other organs. For intracardiac pressure, thermal dilution or piezoelectric sensing principles are usually used for detection. The thermodilution technique is a method of determining the magnitude of intracardiac pressure by detecting temperature changes within the heart or blood vessels due to an indicator fluid by a catheter or guidewire .…”
Section: Clinical Catheter-based Surgical Instrumentsmentioning
confidence: 99%